Skip to content

To study the response of atomoxetine (a drug used in Attention Deficit hyperactivity Disorder) after one week by using (EEG)electroencephalogram in children with (ADHD)attention deficit hyperactivity disorder

Prediction of response to atomoxetine using electroencephalogram in attention deficit hyperactivity disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/02/007888
Enrollment
50
Registered
2017-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ADHD children

Interventions

Intervention1: Tablet or capsule atomoxetine 10 mg/day: Tab atomoxetine 10 mg/day once daily after breakfast to be taken orally for 8 weeks Control Intervention1: not applicable: not applicable

Sponsors

Govt Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children from 6 to 14 years of age with a DSM 5 diagnosis of mild/ moderate/ severe ADHD. 2. Children who are drug naive. 3. Children giving assent and their guardian giving written consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Children who are on medicines that may affect EEG changes. 2. Children with history of physical illness like heart disease, seizures, febrile convulsions etc., any co-morbid mental illness like- bipolar affective disorder, psychosis, pervasive developmental disorder, Oppositional Defiant Disorder, Conduct Disorder, substance abuse, anxiety, mental retardation or tic disorder and any organic condition.

Design outcomes

Primary

MeasureTime frame
The absolute and relative power estimates for the delta, theta, alpha, beta and gamma bands in Electroencephalogram will be recorded.Timepoint: electroencephalogram at 1 week

Secondary

MeasureTime frame
NilTimepoint: N/A

Countries

India

Contacts

Public ContactDr. Priti Arun

GMCH 32, Chandigarh

drpritiarun@gmail.com9646121612

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026